Last update Dec. 22, 2013


High Risk

Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.

On latest update relevant data on breastfeeding were not found.

Since it is usually prescribed for long-term treatment and it does not have a low oral bioavailability, infant coagulation could be affected.

Potential adverse effects would be minimized by delaying nursing for 4-5 hours after last dose and checking-up for infant platelet count.


  • Hydroxycarbamide (Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
  • Interferon alfa ( Safe. Compatible. Minimal risk for breastfeeding and infant.)

Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.


Anagrelide-Hydrochloride belongs to this group or family:


Main tradenames from several countries containing Anagrelide-Hydrochloride in its composition:


Variable Value Unit
Oral Bioavail. 70 %
Molecular weight 311 daltons
Tmax 1 hours
T1/2 1,3 hours


  1. Ramirez G, García-Sanchez R, Plaza S. [Management of patients with essential thrombocythemia]. Med Clin (Barc). 2013 Abstract
  2. EMEA Anagrelida Ficha técnica 2009 Full text (in our servers)
  3. EMEA Anagrelide Data Sheet 2009 Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at

e-lactancia is a resource recommended by IHAN of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM